retatrutide nonalcoholic fatty liver disease nash trial Current therapies and new developments in NASH Pipeline

--- ## Storage and Handling Summary | Condition | Pre-Reconstitution | Post-Reconstitution | |-----------|-------------------|---------------------| | Temperature | Room temp or refrigerator | 28C (refrigerator only) | | Light | Protect from direct light | Protect from light | | Freeze

Clinical trials reported that approximately 5-7% of participants discontinued treatment due to gastrointestinal side effects

Who are GLP-1 receptor agonists for

Bianchi R, Cervellini I, Porretta-Serapiglia C, Oggioni N, Burkey B, Ghezzi P et al (2012) Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy

What Makes Choosing the Right GLP-1 So Crucial